Page last updated: 2024-10-31

muscimol and Cerebellar Diseases

muscimol has been researched along with Cerebellar Diseases in 1 studies

Muscimol: A neurotoxic isoxazole isolated from species of AMANITA. It is obtained by decarboxylation of IBOTENIC ACID. Muscimol is a potent agonist of GABA-A RECEPTORS and is used mainly as an experimental tool in animal and tissue studies.
muscimol : A member of the class of isoxazoles that is 1,2-oxazol-3(2H)-one substituted by an aminomethyl group at position 5. It has been isolated from mushrooms of the genus Amanita.

Cerebellar Diseases: Diseases that affect the structure or function of the cerebellum. Cardinal manifestations of cerebellar dysfunction include dysmetria, GAIT ATAXIA, and MUSCLE HYPOTONIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Neophytides, AN1
Teychenne, PF1
Pfeiffer, RF1
Calne, DB1

Trials

1 trial available for muscimol and Cerebellar Diseases

ArticleYear
Sodium valproate in the treatment of cerebellar disorders.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1979, Volume: 6, Issue:4

    Topics: Cerebellar Diseases; Clonazepam; Double-Blind Method; Female; Humans; Male; Muscimol; Valproic Acid

1979